NVAX vs NXPI · P/E 2.5, rev $196.2M vs P/E 29, rev $12.27B
Novavax Inc (NVAX) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Novavax Inc (NVAX) is a biotechnology company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
NVAX currently screens at market cap $1.09B and trailing P/E 2.5. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the NVAX and NXPI stock pages for the full models.
Not investment advice.